{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:27:59Z","timestamp":1792686479670,"version":"4.5.0"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.2169\/internalmedicine.8934-21","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T22:10:46Z","timestamp":1648246246000},"page":"1775-1777","source":"Crossref","is-referenced-by-count":13,"title":["Polymyalgia Rheumatica Following COVID-19 Vaccination"],"prefix":"10.2169","volume":"61","author":[{"given":"Akira","family":"Yokote","sequence":"first","affiliation":[{"name":"Department of Neurology, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Fujioka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayasu","family":"Mishima","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Tsuboi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Fukuoka University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Gonz\u00e1lez-Gay MA, Matteson EL, Casta\u00f1eda S. Polymyalgia rheumatica. Lancet 390: 1700-1712, 2017.","DOI":"10.1016\/S0140-6736(17)31825-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Liozon E, Parreau S, Filloux M, et al. Giant cell arteritis or polymyalgia rheumatica after influenza vaccination: a study of 12 patients and a literature review. Autoimmun Rev 20: 102732, 2021.","DOI":"10.1016\/j.autrev.2020.102732"},{"key":"3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.5114\/reum.2020.95360","volume":"58","author":"P Falsetti","year":"2020","unstructured":"3. Falsetti P, Conticini E, Acciai C, et al. Polymyalgia rheumatica following infective triggers or vaccinations: a different subset of disease? Reumatologia 58: 76-80, 2020.","journal-title":"Reumatologia\/Rheumatology","ISSN":"https:\/\/id.crossref.org\/issn\/0034-6233","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med 383: 2603-2615, 2020.","DOI":"10.1056\/NEJMoa2034577"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Greinacher A, Thiele T, Warkentin TE, et al. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 384: 2092-2101, 2021.","DOI":"10.1056\/NEJMoa2104840"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Watad A, De Marco G, Mahajna H, et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination. Vaccines (Basel) 9: 435, 2021.","DOI":"10.3390\/vaccines9050435"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Bird HA, Esselinckx W, Dixon AS, et al. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38: 434-439, 1979.","DOI":"10.1136\/ard.38.5.434"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shakoor MT, Birkenbach MP, Lynch M. ANCA-associated vasculitis following the Pfizer-BioNTech COVID-19 vaccine. Am J Kidney Dis 78: 611-613, 2021.","DOI":"10.1053\/j.ajkd.2021.06.016"},{"key":"9","unstructured":"9. Magliulo D, Narayan S, Ue F, et al. Adult-onset Still's disease after mRNA COVID-19 vaccine. Lancet Rheumatol S2665-9913(21)00219-8, 2021."},{"key":"10","doi-asserted-by":"crossref","first-page":"105150","DOI":"10.1016\/j.jbspin.2021.105150","volume":"88","author":"C Manzo","year":"2021","unstructured":"10. Manzo C, Castagna A, Ruotolo G. Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica? Joint Bone Spine 88: 105150, 2021.","journal-title":"Joint Bone Spine","ISSN":"https:\/\/id.crossref.org\/issn\/1297-319X","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Manzo C, Natale M, Castagna A. Polymyalgia rheumatica as uncommon adverse event following immunization with COVID-19 vaccine: a case report and review of literature. Aging Med (Milton) 4: 234-238, 2021.","DOI":"10.1002\/agm2.12171"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Mettler C, Jonville-Bera AP, Grandvuillemin A, et al. Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study. Rheumatology (Oxford) 61: 865-867, 2021.","DOI":"10.1093\/rheumatology\/keab756"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ursini F, Ruscitti P, Raimondo V, et al. Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases. Ann Rheum Dis 81: 440-441, 2021.","DOI":"10.1136\/annrheumdis-2021-221587"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Osada A, Sakuragi C, Toya C, et al. New-onset polymyalgia rheumatica following the administration of the Pfizer-BioNTech COVID-19 vaccine. Intern Med 61: 749-753, 2021.","DOI":"10.2169\/internalmedicine.8651-21"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Haworth S, Ridgeway J, Stewart I, et al. Polymyalgia rheumatica is associated with both HLA-DRB1*0401 and DRB1*0404. Br J Rheumatol 35: 632-635, 1996.","DOI":"10.1093\/rheumatology\/35.7.632"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/11\/61_8934-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T03:31:56Z","timestamp":1654313516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/11\/61_8934-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8934-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"article-number":"8934-21"}}